Umar Wazir
Overview
Explore the profile of Umar Wazir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Varghese J, Patani N, Wazir U, Novintan S, Michell M, Malhotra A, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927878
Recent advances in neoadjuvant systemic therapy (NST) have significantly improved pathologic complete response rates in early breast cancer, challenging the role of axillary lymph node dissection in nose-positive patients. Targeted...
4.
Alamoodi M, Wazir U, Venkataraman J, Almukbel R, Mokbel K
Diagnostics (Basel)
. 2024 Jun;
14(11).
PMID: 38893701
Targeted axillary dissection (TAD), employing marked lymph node biopsy (MLNB) alongside sentinel lymph node biopsy (SLNB), is increasingly recognised for its efficacy in reducing false negative rates (FNRs) in node-positive...
5.
Alamoodi M, Wazir U, Sakr R, Venkataraman J, Mokbel K, Mokbel K
J Clin Med
. 2024 May;
13(10).
PMID: 38792449
De-escalation of axillary surgery is made possible by advancements in both neoadjuvant systemic therapy (NST) and in localisation technology for breast lesions. Magseed, developed in 2013 by Dr. Michael Douk...
6.
Wazir U, Michell M, Alamoodi M, Mokbel K
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611023
SAVI SCOUT or radar reflector localisation (RRL) has proven accurate in localising non-palpable breast and axillary lesions, with minimal interference with MRI. Targeted axillary dissection (TAD), combining marked lymph node...
7.
Alamoodi M, Patani N, Mokbel K, Wazir U, Mokbel K
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398133
Complete axillary lymph node dissection (cALND) was previously the standard of care for breast cancer (BC) patients with axillary node disease or macro-metastases found via sentinel lymph node biopsy (SLNB)....
8.
Alamoodi M, Wazir U, Mokbel K, Patani N, Varghese J, Mokbel K
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444434
Recent advances in systemic treatment for breast cancer have been underpinned by recognising and exploiting subtype-specific vulnerabilities to achieve higher rates of pathologic complete response (pCR) after neo-adjuvant systemic therapy...
9.
Kirwan L, Wazir U, Mokbel K
Plast Reconstr Surg Glob Open
. 2023 Mar;
11(3):e4860.
PMID: 36891568
Methods: Sixteen cases (32 breasts) were reviewed over a 19-year period. The management of the capsule is based on intraoperative findings and not on preoperative evaluation because of the poor...
10.
Wazir U, Patani N, Balalaa N, Mokbel K
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612009
Contrary to traditional assumptions, recent evidence suggests that neoadjuvant systemic therapy (NST) given for invasive breast cancer may eradicate co-existent ductal carcinoma in-situ (DCIS), which may facilitate de-escalation of breast...